Tritium Partners buys into DCS Global through recapitalisation deal


Lower mid-market US buyout house Tritium Partners has backed revenue cycle management software business DCS Global.

The company says it provides admission and financial-clearance options for healthcare providers looking to benefit from accelerated reimbursements, reduced denials, enhanced patient experience, and increased pre-service collections.

Tritium partner Matt Bowman said, “DCS is the best-kept secret for healthcare providers needing front-end solutions to better address patient consumerism and payor reimbursement.
“The company was built by listening to and solving customer needs, and that formula has fueled remarkable customer satisfaction and growth.  We are excited to partner with management to help support the expansion of their market-leading products to a broader base of providers.”
David Lack, a managing partner at Tritium, added, “To-date, DCS has primarily grown through word of mouth, given its reputation for highly functional and impactful patient access products and its dedication to delivering high quality, personalized service to customers.

“We are looking forward to supporting the company’s expansion plans while ensuring it maintains its product and innovation leadership.”

Texas-based Tritium closed its most recent fund in 2015 after rounding up $309m.

Copyright © 2018 AltAssets